Inventor · disambiguated record
Frederic Dargelas
Also filed as: DARGELAS FREDERIC
4 granted patents·10 pending applications·238 citations·filing 2005–2021
82Inventor score
Files withFLAMEL TECH SA4GUIMBERTEAU FLORENCE4FLAMEL IRELAND LTD2AURIGENE DISCOVERY TECH LTD1DARGELAS FREDERIC1
Top patents by PatentIndex Score
14 records- 0197US8652529B2Anti-misuse microparticulate oral pharmaceutical formGUIMBERTEAU FLORENCE·Filed 2006·Granted Feb 18, 2014·78 cites·44 claims
- 0297US8445023B2Anti-misuse microparticulate oral pharmaceutical formGUIMBERTEAU FLORENCE·Filed 2009·Granted May 21, 2013·94 cites·31 claims
- 0396US9023400B2Prolonged-release multimicroparticulate oral pharmaceutical formGUIMBERTEAU FLORENCE·Filed 2007·Granted May 5, 2015·54 cites·55 claims
- 0492US8895063B2Oral dosage form comprising an antimisuse systemGUIMBERTEAU FLORENCE·Filed 2007·Granted Nov 25, 2014·12 cites·42 claims
- 0566US2007264346A1Multimicroparticulate pharmaceutical forms for oral administrationFLAMEL TECH SA·Filed 2007·Application pending·0 cites
- 0664US2014072644A1Anti-misuse microparticulate oral pharmaceutical formFLAMEL TECH SA·Filed 2013·Application pending·0 cites
- 0758US2016338966A1Multimicroparticulate pharmaceutical forms foe oral administrationFLAMEL IRELAND LTD·Filed 2016·Application pending·0 cites
- 0857US2011104266A1Multimicroparticulate pharmaceutical forms for oral administrationFLAMEL TECH SA·Filed 2011·Application pending·0 cites
- 0955US2009220611A1Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising SameDARGELAS FREDERIC·Filed 2006·Application pending·0 cites
- 1050US2007202049A1Oral dosage form comprising an antimisuse systemFLAMEL TECHNOLOGIES INC·Filed 2006·Application pending·0 cites
- 1150US2015313846A1Prolonged-release multimicroparticulate oral pharmaceutical formFLAMEL IRELAND LTD·Filed 2015·Application pending·0 cites
- 1246US2023119355A1Pharmaceutical compositions of a kinase inhibitorAURIGENE DISCOVERY TECH LTD·Filed 2021·Application pending·0 cites
- 1342US2008193540A1Solid, Oral Drug Form Which Has Been Designed to Prevent MisuseFLAMEL TECH SA·Filed 2005·Application pending·0 cites
- 1427US2011275693A1Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine DerivativesUCB PHARMA SA·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →